Stay updated with breaking news from Bellevue group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ADMA Biologics, Inc. (NASDAQ:ADMA – Get Free Report) CEO Adam S. Grossman sold 100,000 shares of the firm’s stock in a transaction dated Friday, June 14th. The shares were sold at an average price of $10.72, for a total value of $1,072,000.00. Following the sale, the chief executive officer now owns 2,081,475 shares of the […] ....
Point72 Asset Management L.P. raised its holdings in shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) by 105.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,756,122 shares of the biopharmaceutical company’s stock after acquiring an additional 1,413,722 shares during the […] ....
Verona Pharma plc (NASDAQ:VRNA – Get Free Report)’s share price rose 8.4% during mid-day trading on Wednesday . The stock traded as high as $14.56 and last traded at $14.49. Approximately 546,673 shares were traded during trading, a decline of 3% from the average daily volume of 565,092 shares. The stock had previously closed at […] ....
Wasatch Advisors LP grew its stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP – Free Report) by 12.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,097,345 shares of the company’s stock after buying an additional 119,738 shares during the quarter. […] ....
Junto Capital Management LP bought a new stake in Oracle Co. (NYSE:ORCL – Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 311,728 shares of the enterprise software provider’s stock, valued at approximately $32,865,000. A number of other institutional investors and hedge funds have also recently […] ....